Live tuberculosis vaccines based onphoPmutants: a step towards clinical trials
Authors:
- Jesus A Gonzalo AsensioJAJesus A Gonzalo Asensio
- Esther PérezEPEsther Pérez
- Brigitte GicquelBGBrigitte Gicquel
- Carlos MartinCMCarlos Martin
- 14 January 2008
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 8 (2) , 201-211
Abstract
(2008). Live tuberculosis vaccines based on phoP mutants: a step towards clinical trials. Expert Opinion on Biological Therapy: Vol. 8, No. 2, pp. 201-211. doi: 10.1517/14712598.8.2.201Keywords
This publication has 82 references indexed in Scilit:
- Vaccine renaissanceNature Reviews Microbiology, 2007
- XDR Tuberculosis — Implications for Global Public HealthNew England Journal of Medicine, 2007
- Global Incidence of Multidrug‐Resistant TuberculosisThe Journal of Infectious Diseases, 2006
- The Development and Impact of Tuberculosis VaccinesCell, 2006
- New drugs being developed for the treatment of tuberculosisExpert Opinion on Investigational Drugs, 2005
- Systematic Molecular Characterization of Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates from SpainJournal of Clinical Microbiology, 2005
- Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosisVaccine, 2005
- How can immunology contribute to the control of tuberculosis?Nature Reviews Immunology, 2001
- Impact of tuberculosis (TB) on HIV-1 activity in dually infected patientsClinical and Experimental Immunology, 2001
- Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovisAIDS, 1997